• Tak Kyu Oh, In-Ae Song, Young-Jae Cho, Cheong Lim, Young-Tae Jeon, Hee-Joon Bae, and You Hwan Jo.
• Department of Anesthesiology and Pain Medicine, Seoul National University Bundang Hospital, Gumi-ro 173 Beon-gil, Bundang-gu, Seongnam 13620, Korea. airohtak@hotmail.com.
• J Clin Med. 2018 Dec 25; 8 (1).

AbstractThis study aimed to investigate the association between preadmission statin use and acute kidney injury (AKI) incidence among critically ill patients who needed admission to the intensive care unit (ICU) for medical care. Medical records of patients admitted to the ICU were reviewed. Patients who continuously took statin for >1 month prior to ICU admission were defined as statin users. We investigated whether preadmission statin use was associated with AKI incidence within 72 h after ICU admission and whether the association differs according to preadmission estimated glomerular filtration rate (eGFR; in mL min-1 1.73 m-2). Among 21,236 patients examined, 5756 (27.1%) were preadmission statin users and 15,480 (72.9%) were non-statin users. Total AKI incidence within 72 h after ICU admission was 31% lower in preadmission statin users than in non-statin users [odds ratio (OR), 0.69; 95% confidence interval (CI), 0.61⁻0.79; p < 0.001]. This association was insignificant among individuals with eGFR <30 mL min-1 1.73 m-2 (p > 0.05). Our results suggested that preadmission statin therapy is associated with a lower incidence of AKI among critically ill patients; however, this effect might not be applicable for patients with eGFR <30 mL min-1 1.73 m-2.

3 keywords...

hide…